Teva And GSK Settle Skinny-Label Dispute

Few Details Revealed Of Deal To End US Litigation Over Coreg Generic

 
• By Dave Wallace
  
GSK and Teva have settled skinny-label litigation over Coreg (Shutterstock)

More from Deals

More from Business